✦ LIBER ✦

The use of preclinical pharmacokinetic and pharmacodynamic data to predict clinical doses: current and future perspectives

✍ Scribed by Paul Morgan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Conserving antibiotics for the future: N

✍ Johan W. Mouton; Paul G. Ambrose; Rafael Canton; George L. Drusano; Stephan Harb 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 844 KB

The use of ziprasidone in clinical pract

✍ Friederike Vogel; Reinhard Gansmüller; Thomas Leiblein; Otto Dietmaier; Hans Was 📂 Article 📅 2009 🏛 Elsevier Science 🌐 French ⚖ 322 KB

Predictive ADMET (Integrative Approaches

✍ Wang, Jianling; Urban, Laszlo 📂 Article 📅 2014 🏛 John Wiley & Sons, Inc. ⚖ 707 KB

Use of low-dose clinical pharmacodynamic

✍ Gould, Janet C.; Kasichayanula, Sreeneeranj; Shepperly, David C.; Boulton, David 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 549 KB

How to optimise antimicrobial prescripti

✍ Jason A. Roberts; Gavin M. Joynt; Gordon Y.S. Choi; Charles D. Gomersall; Jeffre 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 504 KB

Use of the New York PTSD risk score to p

✍ Joseph A. Boscarino; H. Lester Kirchner; Stuart N. Hoffman; Jennifer Sartorius 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 145 KB